PTB-Associated Splicing Factor (PSF) Is a PPARγ-Binding Protein and Growth Regulator of Colon Cancer Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Tsukahara, Tamotsu ^a   Haniu, Hisao ^a   Matsuda, Yoshikazu ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PTB ASSOCIATED SPLICING FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH REGULATION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; PPAR GAMMA; PROTEIN BINDING; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; VACUOLES;

EID: 84874923744     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058749     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Goldberg RM, (2006) Therapy for metastatic colorectal cancer. Oncologist 11: 981-987.
3. Haddad AJ, Bani Hani M, Pawlik TM, Cunningham SC, (2011) Colorectal liver metastases. Int J Surg Oncol 2011: 285840.
4. Issemann I, Green S, (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
5. Evans RM, (2005) The nuclear receptor superfamily: a rosetta stone for physiology. Mol Endocrinol 19: 1429-1438.
6. Tontonoz P, Hu E, Spiegelman BM, (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156.
7. Gupta RA, Brockman JA, Sarraf P, Willson TM, DuBois RN, (2001) Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 276: 29681-29687.
8. Tsukahara T, Hanazawa S, Kobayashi T, Iwamoto Y, Murakami-Murofushi K, (2010) Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor gamma. Prostaglandins Other Lipid Mediat 93: 126-133.
9. Ondrey F, (2009) Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 15: 2-8.
10. Feinstein DL, Spagnolo A, Akar C, Weinberg G, Murphy P, et al. (2005) Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key? Biochem Pharmacol 70: 177-188.
11. Liu DC, Zang CB, Liu HY, Possinger K, Fan SG, et al. (2004) A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells. Acta Pharmacol Sin 25: 1312-1319.
12. Patton JG, Porro EB, Galceran J, Tempst P, Nadal-Ginard B, (1993) Cloning and characterization of PSF, a novel pre-mRNA splicing factor. Genes Dev 7: 393-406.
13. Urban RJ, Bodenburg Y, (2002) PTB-associated splicing factor regulates growth factor-stimulated gene expression in mammalian cells. Am J Physiol Endocrinol Metab 283: E794-798.
14. Song X, Sun Y, Garen A, (2005) Roles of PSF protein and VL30 RNA in reversible gene regulation. Proc Natl Acad Sci U S A 102: 12189-12193.
15. Song X, Sui A, Garen A, (2004) Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. Proc Natl Acad Sci U S A 101: 621-626.
16. Wang G, Cui Y, Zhang G, Garen A, Song X, (2009) Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA. Proc Natl Acad Sci U S A 106: 16794-16798.
17. O'Malley BW, Kumar R, (2009) Nuclear receptor coregulators in cancer biology. Cancer Res 69: 8217-8222.
18. Bull AW, (2003) The role of peroxisome proliferator-activated receptor gamma in colon cancer and inflammatory bowel disease. Arch Pathol Lab Med 127: 1121-1123.
19. Tsukahara T, Haniu H, (2012) Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells. Biochem Biophys Res Commun 424: 524-529.
20. Haniu H, Komori N, Takemori N, Singh A, Ash JD, et al. (2006) Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina. Proteomics 6: 3251-3261.
21. Tsukahara T, Tsukahara R, Yasuda S, Makarova N, Valentine WJ, et al. (2006) Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma. J Biol Chem 281: 3398-3407.
22. Tsukahara T, Tsukahara R, Fujiwara Y, Yue J, Cheng Y, et al. (2010) Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. Mol Cell 39: 421-432.
23. Mathur M, Tucker PW, Samuels HH, (2001) PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors. Mol Cell Biol 21: 2298-2311.
24. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, et al. (1999) Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res 90: 75-80.
25. Porter AG, Janicke RU, (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104.
26. Barnett DK, Kimura J, Bavister BD, (1996) Translocation of active mitochondria during hamster preimplantation embryo development studied by confocal laser scanning microscopy. Dev Dyn 205: 64-72.
27. Dong X, Shylnova O, Challis JR, Lye SJ, (2005) Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem 280: 13329-13340.
28. Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, et al. (2000) Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Br J Cancer 83: 1394-1400.
29. Mueller E, Sarraf P, Tontonoz P, Evans RM, Martin KJ, et al. (1998) Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1: 465-470.
30. Radhakrishnan SK, Gartel AL, (2005) The PPAR-gamma agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines. Cell Cycle 4: 582-584.
31. Saltiel AR, Olefsky JM, (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669.
32. Koeffler HP, (2003) Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 9: 1-9.
33. Choi IK, Kim YH, Kim JS, Seo JH, (2008) PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. Invest New Drugs 26: 283-288.
34. Lefebvre AM, Chen I, Desreumaux P, Najib J, Fruchart JC, et al. (1998) Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 4: 1053-1057.
35. Saez E, Tontonoz P, Nelson MC, Alvarez JG, Ming UT, et al. (1998) Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat Med 4: 1058-1061.
36. Henics T, Wheatley DN, (1999) Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biol Cell 91: 485-498.
37. Liu X, Kim CN, Yang J, Jemmerson R, Wang X, (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
38. Yuqi L, Lei G, Yang L, Zongbin L, Hua X, et al. (2009) Voltage-dependent anion channel (VDAC) is involved in apoptosis of cell lines carrying the mitochondrial DNA mutation. BMC Med Genet 10: 114.
39. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ, (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517.
40. Plotz M, Gillissen B, Hossini AM, Daniel PT, Eberle J (2012) Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells. Cell Death Differ.
41. Chandra D, Choy G, Daniel PT, Tang DG, (2005) Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J Biol Chem 280: 19051-19061.
42. Borutaite V, Brown GC, (2001) Caspases are reversibly inactivated by hydrogen peroxide. FEBS Lett 500: 114-118.
43. Borutaite V, (2010) Mitochondria as decision-makers in cell death. Environ Mol Mutagen 51: 406-416.